Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation

• DOI: 10.1186/s12964-019-0444-1
• Publication Date: 2019-10-17T14:59:24Z
• Authors: Yi-Heng Hao; M. Carmen Lafita-...; Lauren Zacharias; Nofit Borenstein-...; Min Kim; Spencer Barnes; Jiwoong Kim; Jerry Shay; Ralph J. DeBerard...; Maralice Conacci-...
• Keywords: Transcriptional Activation; 0301 basic medicine; Lymphoid Enhancer-Binding Factor 1; MYC; Proto-Oncogene Mas; Cell Line; Proto-Oncogene Proteins c-myc; 03 medical and health sciences; Acyl-CoA Dehydrogenases; LEF1; Humans; PPAR delta; Wnt Signaling Pathway; beta Catenin; Cell Proliferation; WNT/β-catenin pathway; QH573-671; Research; R; Colon cancer; 3. Good health; Metabolism; Gene Knockdown Techniques; Tumorigenesis; Colonic Neoplasms; Medicine; Cytology

Abstract

Background While regulated WNT activity is required for normal development and stem cell maintenance, mutations that lead to constitutive activation of the WNT pathway cause cellular transformation and drive colorectal cancer. Activation of the WNT pathway ultimately leads to the nuclear translocation of β-catenin which, in complex with TCF/LEF factors, promotes the transcription of genes necessary for growth. The proto-oncogene MYC is one of the most critical genes activated downstream the WNT pathway in colon cancer. Here, we investigate the converse regulation of the WNT pathway by MYC.

Methods We performed RNA-seq analyses to identify genes regulated in cells expressing MYC. We validated the regulation of genes in the WNT pathway including LEF1 by MYC using RT-qPCR, Western blotting, and ChIP-seq. We investigated the importance of LEF1 for the viability of MYC-expressing cells in in fibroblasts, epithelial cells, and colon cells. Bioinformatic analyses were utilized to define the expression of MYC-regulated genes in human colon cancer and metabolomics analyses were used to identify pathways regulated by LEF1 in MYC expressing cells.

Results MYC regulates the levels of numerous WNT-related genes, including the β-catenin co-transcription factor LEF1. MYC activates the transcription of LEF1 and is required for LEF1 expression in colon cancer cells and in primary colonic cells transformed by APC loss of function, a common mutation in colon cancer patients. LEF1 caused the retention of β-catenin in the nucleus, leading to the activation of the WNT pathway in MYC-expressing cells. Consequently, MYC-expressing cells were sensitive to LEF1 inhibition. Moreover, we describe two examples of genes induced in MYC-expressing cells that require LEF1 activity: the peroxisome proliferator activated receptor delta (PPARδ) and the Acyl CoA dehydrogenase 9 (ACAD9).

Conclusions We demonstrated that MYC is a transcriptional regulator of LEF1 in colonic cells. Our work proposes a novel pathway by which MYC regulates proliferation through activating LEF1 expression which in turn activates the WNT pathway.

Graphical Abstract